CD38 and COVID-19: In the COVID-19(+) group there was a significantly positive correlation between the percentage of RE-LYMP and CD4+ CD38+ lymphocytes (R = 0.5, p < 0.05) and between the percentage of RE-LYMP and GMF CD8+ CD45RO intensity (R = 0.7, p < 0.05).